FDA NDC Directory · JSON-LD · Markdown

Balsalazide Disodium

NDC 60505-2575 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA077883
Dosage form / routeCAPSULE · ORAL
Active ingredientsBALSALAZIDE DISODIUM (750 mg/1)
Marketing started20071228
Package count4

External sources

Source: openFDA. Public-domain (CC0).